Similasan Hautausschläge, Globuli

7680508840174 CH-50884 Globuli
Similasan Hautausschläge, Globuli
Similasan Hautausschläge, Globuli
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
15
Selling units
15
Measure
g
Galenic form
Globuli
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/04/2026
Patient information leaflet
Français
02/04/2026
Patient information leaflet
Italien
02/04/2026

Detailed composition

Substance Quantity Type Category
mercurius solubilis hahnemanni (HAB)
2.5 MG Substance Wirkstoff (Principe actif)
natrium chloratum (HAB)
2.5 MG Substance Wirkstoff (Principe actif)
rhus toxicodendron (HAB)
2.5 MG Substance Wirkstoff (Principe actif)
selenium (HAB)
2.5 MG Substance Wirkstoff (Principe actif)
calcii carbonas
- Substance HNIDK
xylitolum
600.0 MG Substance HBESI

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
50884
Drug name
Similasan Hautausschläge, Globuli
Galenic form
GLO
Authorization status
Z
Dispensing category
D
First authorization
15/07/1991
Authorization expiration date
31/12/9999
IT Number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei Hautausschlägen und Ekzemen

Package details

Description (FR)
SIMILASAN Affections cutanées glob 15 g
Description (DE)
SIMILASAN Hautausschläge Glob 15 g
Market launch
15/07/1991
Narcotic (BTM)
No

Other package sizes (3)

SIMILASAN globules affections cutanées 15 g
None None
GTIN: 7680508840150
Not in V1
None
None None
GTIN: None
Not in V1
None
4.5 G
GTIN: None
Not in V1
Buy us a coffee Explore the data